29
Views
14
CrossRef citations to date
0
Altmetric
The John Pratt-Johnson Annual Lecture

Refractive Surgery in Children: Is it Ready for Prime Time?

, M.D.
Pages 79-88 | Published online: 22 Dec 2017
 

Abstract

Introduction

Potential indications for excimer laser procedures in children include accommodative esotropia, bilateral high ametropia, and severe anisometropia. Treatment of these conditions has traditionally included spectacle or contact lens use. This treatment, however, is often ineffective in children with severe anisometropia or bilateral ametropia, especially those with neuropsychological disorders. Refractive surgery may be a viable treatment option for these conditions.

Methods

The visual and refractive results from our studies on photorefractive keratectomy for pediatric anisometropic amblyopia are discussed. Also, I will present a review of the world literature on excimer laser procedures for accommodative esotropia, pediatric high anisometropia, and pediatric bilateral high ametropia.

Results

In our study, at 36 months follow-up, 7 of 9 patients who were able to perform psychophysical acuity testing preoperatively had improvement of two or more lines of uncorrected visual acuity and 6 of 9 had improvement of two or more lines of best corrected visual acuity. Fifty percent of the myopic patients and 100% of the hyperopic patients were within 2 D of refractive target at the 36-month follow-up visit. Refractive error stability has been good and corneal haze has been minimal.

Conclusions

Refractive surgery in children to reduce amblyopiogenic levels of refractive error is proving to be relatively stable. Best corrected and uncorrected visual acuity has also been shown to improve following the excimer laser procedures. Refractive surgery also appears to be effective for pure accommodative esotropia. Randomized clinical trials are needed to fully establish safety and efficacy. Other refractive procedures, such as clear lens extraction and phakic intraocular lenses, may also prove to be valid treatment options for these conditions in the future.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.